Organization Statistics
Avg Compliance Rate
48.60%
Compliant Trials
486
Incompliant submissions
514
Total Organizations
46697
Total trials
1000
Filter Organizations
Compare Organization Compliance Rates
Showing 725 of 46697 entries
View as:
0.0% Compliant
Total: 2
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 9
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 4
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 3
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 7
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 4
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 17
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 3
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 27
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 2
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 6
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 10
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 2
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 3
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 16
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 2
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 4
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 4
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
| Sponsor | Funding Source | Total Trials | Reporting Rate | Compliant Trials | Late Submissions | Compliance Rate | Wilson LCB Score | Email Domain | Created Date |
|---|---|---|---|---|---|---|---|---|---|
| Acadia University | - | 2 | 0.0% | 0 | 0 | 0.0% | - | Acadia University.temp.org | 2025-07-14 |
| Acandis GmbH | - | 9 | 0.0% | 0 | 0 | 0.0% | - | Acandis GmbH.temp.org | 2025-07-14 |
| Acanthas Pharma Inc | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Acanthas Pharma Inc.temp.org | 2025-07-14 |
| Acarix | - | 4 | 0.0% | 0 | 0 | 0.0% | - | Acarix.temp.org | 2025-07-14 |
| Accademia Italiana Medicina Osteopatica | - | 3 | 0.0% | 0 | 0 | 0.0% | - | Accademia Italiana Medicina Osteopatica.temp.org | 2025-07-14 |
| Accare | - | 7 | 0.0% | 0 | 0 | 0.0% | - | Accare.temp.org | 2025-07-14 |
| Accelerate Diagnostics, Inc. | - | 4 | 0.0% | 0 | 0 | 0.0% | - | Accelerate Diagnostics, Inc..temp.org | 2025-07-14 |
| Accelerated Community Oncology Research Network | - | 17 | 0.0% | 0 | 0 | 0.0% | - | Accelerated Community Oncology Research Network.temp.org | 2025-07-14 |
| Accelerated Cure Project for Multiple Sclerosis | - | 3 | 0.0% | 0 | 0 | 0.0% | - | Accelerated Cure Project for Multiple Sclerosis.temp.org | 2025-07-14 |
| Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA | - | 27 | 0.0% | 0 | 0 | 0.0% | - | Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA.temp.org | 2025-07-14 |
| Accendatech USA Inc. | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Accendatech USA Inc..temp.org | 2025-07-14 |
| Accent Therapeutics | - | 2 | 0.0% | 0 | 0 | 0.0% | - | Accent Therapeutics.temp.org | 2025-07-14 |
| Accentia Biopharmaceuticals | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Accentia Biopharmaceuticals.temp.org | 2025-07-14 |
| Accenture | - | 6 | 0.0% | 0 | 0 | 0.0% | - | Accenture.temp.org | 2025-07-14 |
| Access Business Group | - | 10 | 0.0% | 0 | 0 | 0.0% | - | Access Business Group.temp.org | 2025-07-14 |
| Access Pharmaceuticals, Inc. | - | 2 | 0.0% | 0 | 0 | 0.0% | - | Access Pharmaceuticals, Inc..temp.org | 2025-07-14 |
| Access Vascular Inc | - | 3 | 0.0% | 0 | 0 | 0.0% | - | Access Vascular Inc.temp.org | 2025-07-14 |
| Access to Advanced Health Institute (AAHI) | - | 16 | 0.0% | 0 | 0 | 0.0% | - | Access to Advanced Health Institute (AAHI).temp.org | 2025-07-14 |
| AccessBio, Inc. | - | 2 | 0.0% | 0 | 0 | 0.0% | - | AccessBio, Inc..temp.org | 2025-07-14 |
| Accession Therapeutics Limited | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Accession Therapeutics Limited.temp.org | 2025-07-14 |
| Accexible | - | 4 | 0.0% | 0 | 0 | 0.0% | - | Accexible.temp.org | 2025-07-14 |
| Accriva Diagnostics | - | 4 | 0.0% | 0 | 0 | 0.0% | - | Accriva Diagnostics.temp.org | 2025-07-14 |
| Accro Bioscience (Suzhou) Limited | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Accro Bioscience (Suzhou) Limited.temp.org | 2025-07-14 |
| Accuitis, Inc. | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Accuitis, Inc..temp.org | 2025-07-14 |
| Accumbo AB | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Accumbo AB.temp.org | 2025-07-14 |